 MARSEILLE, France--BUSINESS WIRE--Regulatory News: Innate Pharma SA Euronext Paris: IPH; Nasdaq: IPHA Innate or the Company, today announced that the Company will hold a conference call on Tuesday, November 16, 2021, at 2 p.m. CET 8 a.m. ET, to give an update on business progress during the third quarter of 2021. Participating in the call will be Innates Chief Executive Officer Mondher Mahjoubi, MD and Chief Medical Officer Joyson Karakunnel, MD, MSc, FACP. Details for the Virtual 